Cargando…

Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models

Bone morphogenetic protein (BMP) signaling is critical in skeletal development. Overactivation can trigger heterotopic ossification (HO) as in fibrodysplasia ossificans progressiva (FOP), a rare, progressive disease of massive HO formation. A small subset of FOP patients harboring the causative ACVR...

Descripción completa

Detalles Bibliográficos
Autores principales: Wentworth, Kelly L., Lalonde, Robert L., Groppe, Jay C., Brewer, Niambi, Moody, Tania, Hansberry, Steven, Taylor, Kimberly E., Shore, Eileen M., Kaplan, Frederick S., Pignolo, Robert J., Yelick, Pamela C., Hsiao, Edward C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950781/
https://www.ncbi.nlm.nih.gov/pubmed/36153796
http://dx.doi.org/10.1002/jbmr.4711
_version_ 1784893246431821824
author Wentworth, Kelly L.
Lalonde, Robert L.
Groppe, Jay C.
Brewer, Niambi
Moody, Tania
Hansberry, Steven
Taylor, Kimberly E.
Shore, Eileen M.
Kaplan, Frederick S.
Pignolo, Robert J.
Yelick, Pamela C.
Hsiao, Edward C.
author_facet Wentworth, Kelly L.
Lalonde, Robert L.
Groppe, Jay C.
Brewer, Niambi
Moody, Tania
Hansberry, Steven
Taylor, Kimberly E.
Shore, Eileen M.
Kaplan, Frederick S.
Pignolo, Robert J.
Yelick, Pamela C.
Hsiao, Edward C.
author_sort Wentworth, Kelly L.
collection PubMed
description Bone morphogenetic protein (BMP) signaling is critical in skeletal development. Overactivation can trigger heterotopic ossification (HO) as in fibrodysplasia ossificans progressiva (FOP), a rare, progressive disease of massive HO formation. A small subset of FOP patients harboring the causative ACVR1 ( R206H ) mutation show strikingly mild or delayed‐onset HO, suggesting that genetic variants in the BMP pathway could act as disease modifiers. Whole‐exome sequencing of one such patient identified BMPR1A ( R443C ) and ACVR2A ( V173I ) as candidate modifiers. Molecular modeling predicted significant structural perturbations. Neither variant decreased BMP signaling in ACVR1 ( R206H ) HEK 293T cells at baseline or after stimulation with BMP4 or activin A (AA), ligands that activate ACVR1(R206H) signaling. Overexpression of BMPR1A ( R443C ) in a Tg(ACVR1‐R206Ha) embryonic zebrafish model, in which overactive BMP signaling yields ventralized embryos, did not alter ventralization severity, while ACVR2A ( V173I ) exacerbated ventralization. Co‐expression of both variants did not affect dorsoventral patterning. In contrast, BMPR1A knockdown in ACVR1 ( R206H ) HEK cells decreased ligand‐stimulated BMP signaling but did not affect dorsoventral patterning in Tg(ACVR1‐R206Ha) zebrafish. ACVR2A knockdown decreased only AA‐stimulated signaling in ACVR1 ( R206H ) HEK cells and had no effect in Tg(ACVR1‐R206Ha) zebrafish. Co‐knockdown in ACVR1 ( R206H ) HEK cells decreased basal and ligand‐stimulated signaling, and co‐knockdown/knockout (bmpr1aa/ab; acvr2aa/ab) decreased Tg(ACVR1‐R206Ha) zebrafish ventralization phenotypes. Our functional studies showed that knockdown of wild‐type BMPR1A and ACVR2A could attenuate ACVR1(R206H) signaling, particularly in response to AA, and that ACVR2A ( V173I ) unexpectedly increased ACVR1(R206H)‐mediated signaling in zebrafish. These studies describe a useful strategy and platform for functionally interrogating potential genes and genetic variants that may impact the BMP signaling pathway. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
format Online
Article
Text
id pubmed-9950781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-99507812023-04-14 Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models Wentworth, Kelly L. Lalonde, Robert L. Groppe, Jay C. Brewer, Niambi Moody, Tania Hansberry, Steven Taylor, Kimberly E. Shore, Eileen M. Kaplan, Frederick S. Pignolo, Robert J. Yelick, Pamela C. Hsiao, Edward C. J Bone Miner Res Research Articles Bone morphogenetic protein (BMP) signaling is critical in skeletal development. Overactivation can trigger heterotopic ossification (HO) as in fibrodysplasia ossificans progressiva (FOP), a rare, progressive disease of massive HO formation. A small subset of FOP patients harboring the causative ACVR1 ( R206H ) mutation show strikingly mild or delayed‐onset HO, suggesting that genetic variants in the BMP pathway could act as disease modifiers. Whole‐exome sequencing of one such patient identified BMPR1A ( R443C ) and ACVR2A ( V173I ) as candidate modifiers. Molecular modeling predicted significant structural perturbations. Neither variant decreased BMP signaling in ACVR1 ( R206H ) HEK 293T cells at baseline or after stimulation with BMP4 or activin A (AA), ligands that activate ACVR1(R206H) signaling. Overexpression of BMPR1A ( R443C ) in a Tg(ACVR1‐R206Ha) embryonic zebrafish model, in which overactive BMP signaling yields ventralized embryos, did not alter ventralization severity, while ACVR2A ( V173I ) exacerbated ventralization. Co‐expression of both variants did not affect dorsoventral patterning. In contrast, BMPR1A knockdown in ACVR1 ( R206H ) HEK cells decreased ligand‐stimulated BMP signaling but did not affect dorsoventral patterning in Tg(ACVR1‐R206Ha) zebrafish. ACVR2A knockdown decreased only AA‐stimulated signaling in ACVR1 ( R206H ) HEK cells and had no effect in Tg(ACVR1‐R206Ha) zebrafish. Co‐knockdown in ACVR1 ( R206H ) HEK cells decreased basal and ligand‐stimulated signaling, and co‐knockdown/knockout (bmpr1aa/ab; acvr2aa/ab) decreased Tg(ACVR1‐R206Ha) zebrafish ventralization phenotypes. Our functional studies showed that knockdown of wild‐type BMPR1A and ACVR2A could attenuate ACVR1(R206H) signaling, particularly in response to AA, and that ACVR2A ( V173I ) unexpectedly increased ACVR1(R206H)‐mediated signaling in zebrafish. These studies describe a useful strategy and platform for functionally interrogating potential genes and genetic variants that may impact the BMP signaling pathway. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). John Wiley & Sons, Inc. 2022-11-15 2022-11 /pmc/articles/PMC9950781/ /pubmed/36153796 http://dx.doi.org/10.1002/jbmr.4711 Text en © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Wentworth, Kelly L.
Lalonde, Robert L.
Groppe, Jay C.
Brewer, Niambi
Moody, Tania
Hansberry, Steven
Taylor, Kimberly E.
Shore, Eileen M.
Kaplan, Frederick S.
Pignolo, Robert J.
Yelick, Pamela C.
Hsiao, Edward C.
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
title Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
title_full Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
title_fullStr Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
title_full_unstemmed Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
title_short Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1(R206H) ‐Specific Human Cellular and Zebrafish Models
title_sort functional testing of bone morphogenetic protein (bmp) pathway variants identified on whole‐exome sequencing in a patient with delayed‐onset fibrodysplasia ossificans progressiva (fop) using acvr1(r206h) ‐specific human cellular and zebrafish models
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950781/
https://www.ncbi.nlm.nih.gov/pubmed/36153796
http://dx.doi.org/10.1002/jbmr.4711
work_keys_str_mv AT wentworthkellyl functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT lalonderobertl functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT groppejayc functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT brewerniambi functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT moodytania functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT hansberrysteven functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT taylorkimberlye functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT shoreeileenm functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT kaplanfredericks functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT pignolorobertj functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT yelickpamelac functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels
AT hsiaoedwardc functionaltestingofbonemorphogeneticproteinbmppathwayvariantsidentifiedonwholeexomesequencinginapatientwithdelayedonsetfibrodysplasiaossificansprogressivafopusingacvr1r206hspecifichumancellularandzebrafishmodels